These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 1921261)
21. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients. Conzelmann M; Linnemann U; Berger MR Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598 [TBL] [Abstract][Full Text] [Related]
22. Nucleotide sequence of canine c-N-ras: codons 1 to 71. Saunders KA; Madewell BR; Oreffo VI; Kraegel SA; Gumerlock PH Am J Vet Res; 1992 Apr; 53(4):600-3. PubMed ID: 1586036 [TBL] [Abstract][Full Text] [Related]
23. No evidence for point mutations in codons 12, 13, and 61 of the ras gene in a high-incidence area for esophageal and gastric cancers. Victor T; Du Toit R; Jordaan AM; Bester AJ; van Helden PD Cancer Res; 1990 Aug; 50(16):4911-4. PubMed ID: 2199031 [TBL] [Abstract][Full Text] [Related]
24. K-ras point mutations are rare events in premalignant forms of Barrett's oesophagus. Trautmann B; Wittekind C; Strobel D; Meixner H; Keymling J; Gossner L; Ell C; Hahn EG Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):799-804. PubMed ID: 8864678 [TBL] [Abstract][Full Text] [Related]
25. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. Albino AP; Nanus DM; Mentle IR; Cordon-Cardo C; McNutt NS; Bressler J; Andreeff M Oncogene; 1989 Nov; 4(11):1363-74. PubMed ID: 2682463 [TBL] [Abstract][Full Text] [Related]
26. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Smith AJ; Stern HS; Penner M; Hay K; Mitri A; Bapat BV; Gallinger S Cancer Res; 1994 Nov; 54(21):5527-30. PubMed ID: 7923190 [TBL] [Abstract][Full Text] [Related]
27. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9. Kumar R; Angelini S; Hemminki K Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681 [TBL] [Abstract][Full Text] [Related]
28. [Immunoglobulin heavy chain gene rearrangements in the monoclonal gammopathies]. Bosaleh A; Denninghoff V; Garcia A; Rescia C; Avagnina A; Elsner B Medicina (B Aires); 2005; 65(3):219-25. PubMed ID: 16042132 [TBL] [Abstract][Full Text] [Related]
29. Retrospective analysis of ras gene activation in myeloid leukemic cells. Lübbert M; Jonas D; Miller CW; Herrmann F; Mertelsmann R; McCormick F; Koeffler HP Oncogene; 1990 Apr; 5(4):583-7. PubMed ID: 2183160 [TBL] [Abstract][Full Text] [Related]
30. Presence of mutations in all three ras genes in human thyroid tumors. Suarez HG; du Villard JA; Severino M; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R Oncogene; 1990 Apr; 5(4):565-70. PubMed ID: 2183158 [TBL] [Abstract][Full Text] [Related]
31. [Molecular study on minute alterations of the p53 and the N-ras genes in hematologic malignancies]. Kurosawa M Hokkaido Igaku Zasshi; 1994 May; 69(3):543-54. PubMed ID: 7927179 [TBL] [Abstract][Full Text] [Related]
32. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis. Lang SM; Heinzlmann M; Stratakis DF; Teschauer W; Loeschke K Am J Gastroenterol; 1997 Dec; 92(12):2166-70. PubMed ID: 9399746 [TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients. Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679 [TBL] [Abstract][Full Text] [Related]
34. Absence of point mutation of N-ras oncogene in bone marrow cells with aplastic anemia. Shinohara K; Yujiri T; Kamei S; Ayame H; Tanaka M; Ando S; Tajiri M Int J Cell Cloning; 1992 Mar; 10(2):94-8. PubMed ID: 1545154 [TBL] [Abstract][Full Text] [Related]
35. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Suzuki Y; Orita M; Shiraishi M; Hayashi K; Sekiya T Oncogene; 1990 Jul; 5(7):1037-43. PubMed ID: 2197591 [TBL] [Abstract][Full Text] [Related]
36. Relevance of Ras gene mutations in the context of the molecular heterogeneity of multiple myeloma. Intini D; Agnelli L; Ciceri G; Ronchetti D; Fabris S; Nobili L; Lambertenghi-Deliliers G; Lombardi L; Neri A Hematol Oncol; 2007 Mar; 25(1):6-10. PubMed ID: 17036375 [TBL] [Abstract][Full Text] [Related]
37. Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma. Chim CS; Liang R; Leung MH; Kwong YL J Clin Pathol; 2007 Jan; 60(1):104-6. PubMed ID: 17213358 [TBL] [Abstract][Full Text] [Related]
39. Reduction of serum IGF-I levels in patients affected with Monoclonal Gammopathies of undetermined significance or Multiple Myeloma. Comparison with bFGF, VEGF and K-ras gene mutation. Greco C; Vitelli G; Vercillo G; Vona R; Giannarelli D; Sperduti I; Pisani F; Capoluongo E; Petti MC; Ameglio F J Exp Clin Cancer Res; 2009 Mar; 28(1):35. PubMed ID: 19284554 [TBL] [Abstract][Full Text] [Related]
40. Mutation analysis of the ras gene in myelocytic leukemia by polymerase chain reaction and oligonucleotide probes. Liu TC; Lin SF; Chen TP; Liu HW; Chang JG J Formos Med Assoc; 1991 Sep; 90(9):825-30. PubMed ID: 1683380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]